In Depth

Featured article

China takes lead in CGT trials amid Western funding challenges

Also in this section

As US funding falters, mRNA cancer vaccine pioneers face new hurdles

Europe’s cannabis pharmaceuticals market matures amid cautious investment

Animal testing alternatives to dominate, but not overnight

One platform can bring countless gains to clinical trial financial management

Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM

09/22/2025 15:11:51
  • Home | China's CGT edge
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Syngene Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Zenatek Company Insight
  • Simtra
  • Alphial Company Insight
  • TriLink BioTechnologies
  • In Depth
  • China takes lead in CGT trials amid Western funding challenges
  • As US funding falters, mRNA cancer vaccine pioneers face new hurdles
  • Europe’s cannabis pharmaceuticals market matures amid cautious investment
  • Animal testing alternatives to dominate, but not overnight
  • One platform can bring countless gains to clinical trial financial management
  • Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM
  • AlfatestLAB Company Insight
  • Gerteis
  • Listings
  • Events
  • Excellence Awards
  • Buyer's Guides
  • Next issue
09/22/2025 00:00:00